Does a multimarker strategy using Troponin, CRP, and BNP improve risk stratification for major cardiac events in patients with Non-ST Elevation Acute Coronary Syndromes?
Combining Troponin, CRP, and BNP into a simple multimarker strategy provides effective short- and long-term risk stratification for patients with NSTE-ACS.
Troponin, CRP, and BNP each provide unique prognostic information in patients with ACS. A simple multimarker strategy that categorizes patients based on the number of elevated biomarkers at presentation allows risk stratification over a broad range of short- and long-term major cardiac events.
Sabatine et al. (2002) studied this question.